Mon, 21 Sep 2020 13:53:24 GMT
Illumina to acquire cancer testing firm Grail
Illumina, the gene sequencing firm, is set to acquire Grail Inc, the Jeff Bezos-backed cancer screening start-up, in a cash-and-stock deal worth $8.0B, both companies announced on Monday.